位置:首页 > 蛋白库 > MCES_YEAST
MCES_YEAST
ID   MCES_YEAST              Reviewed;         436 AA.
AC   P32783; D6VQN2; Q6B2G0;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 1.
DT   03-AUG-2022, entry version 176.
DE   RecName: Full=mRNA cap guanine-N7 methyltransferase;
DE            EC=2.1.1.56 {ECO:0000250|UniProtKB:O43148};
DE   AltName: Full=mRNA (guanine-N(7))-methyltransferase;
DE   AltName: Full=mRNA cap methyltransferase;
GN   Name=ABD1; OrderedLocusNames=YBR236C; ORFNames=YBR1602;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Corrado K., Pringle J.R.;
RT   "Molecular analysis of the ABD1 gene of Saccharomyces cerevisiae, a gene
RT   that displays mutational synergism with the bud formation gene BEM1.";
RL   Submitted (MAY-1993) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=7813418; DOI=10.1002/j.1460-2075.1994.tb06923.x;
RA   Feldmann H., Aigle M., Aljinovic G., Andre B., Baclet M.C., Barthe C.,
RA   Baur A., Becam A.-M., Biteau N., Boles E., Brandt T., Brendel M.,
RA   Brueckner M., Bussereau F., Christiansen C., Contreras R., Crouzet M.,
RA   Cziepluch C., Demolis N., Delaveau T., Doignon F., Domdey H.,
RA   Duesterhus S., Dubois E., Dujon B., El Bakkoury M., Entian K.-D.,
RA   Feuermann M., Fiers W., Fobo G.M., Fritz C., Gassenhuber J., Glansdorff N.,
RA   Goffeau A., Grivell L.A., de Haan M., Hein C., Herbert C.J.,
RA   Hollenberg C.P., Holmstroem K., Jacq C., Jacquet M., Jauniaux J.-C.,
RA   Jonniaux J.-L., Kallesoee T., Kiesau P., Kirchrath L., Koetter P.,
RA   Korol S., Liebl S., Logghe M., Lohan A.J.E., Louis E.J., Li Z.Y.,
RA   Maat M.J., Mallet L., Mannhaupt G., Messenguy F., Miosga T., Molemans F.,
RA   Mueller S., Nasr F., Obermaier B., Perea J., Pierard A., Piravandi E.,
RA   Pohl F.M., Pohl T.M., Potier S., Proft M., Purnelle B., Ramezani Rad M.,
RA   Rieger M., Rose M., Schaaff-Gerstenschlaeger I., Scherens B.,
RA   Schwarzlose C., Skala J., Slonimski P.P., Smits P.H.M., Souciet J.-L.,
RA   Steensma H.Y., Stucka R., Urrestarazu L.A., van der Aart Q.J.M.,
RA   Van Dyck L., Vassarotti A., Vetter I., Vierendeels F., Vissers S.,
RA   Wagner G., de Wergifosse P., Wolfe K.H., Zagulski M., Zimmermann F.K.,
RA   Mewes H.-W., Kleine K.;
RT   "Complete DNA sequence of yeast chromosome II.";
RL   EMBO J. 13:5795-5809(1994).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=17322287; DOI=10.1101/gr.6037607;
RA   Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F.,
RA   Camargo A.A., Kelley F., McCarron S., Jepson D., Richardson A., Raphael J.,
RA   Moreira D., Taycher E., Zuo D., Mohr S., Kane M.F., Williamson J.,
RA   Simpson A.J.G., Bulyk M.L., Harlow E., Marsischky G., Kolodner R.D.,
RA   LaBaer J.;
RT   "Approaching a complete repository of sequence-verified protein-encoding
RT   clones for Saccharomyces cerevisiae.";
RL   Genome Res. 17:536-543(2007).
RN   [5]
RP   FUNCTION.
RX   PubMed=7623811; DOI=10.1128/mcb.15.8.4167;
RA   Mao X., Schwer B., Shuman S.;
RT   "Yeast mRNA cap methyltransferase is a 50-kilodalton protein encoded by an
RT   essential gene.";
RL   Mol. Cell. Biol. 15:4167-4174(1995).
RN   [6]
RP   MUTAGENESIS OF GLY-174; ASP-178; HIS-253; TYR-254; THR-282; GLU-287;
RP   GLU-361 AND TYR-362.
RX   PubMed=8552073; DOI=10.1128/mcb.16.2.475;
RA   Mao X., Schwer B., Shuman S.;
RT   "Mutational analysis of the Saccharomyces cerevisiae ABD1 gene: cap
RT   methyltransferase activity is essential for cell growth.";
RL   Mol. Cell. Biol. 16:475-480(1996).
RN   [7]
RP   MUTAGENESIS OF VAL-168; GLU-170; GLY-172; GLY-176; LYS-181; TYR-182;
RP   ASP-194; ARG-206; TYR-254; GLY-276; GLY-277; GLU-347; TYR-348; VAL-349;
RP   VAL-350; GLY-363; LEU-366; VAL-367 AND PHE-372.
RX   PubMed=9169431; DOI=10.1074/jbc.272.23.14683;
RA   Wang S.P., Shuman S.;
RT   "Structure-function analysis of the mRNA cap methyltransferase of
RT   Saccharomyces cerevisiae.";
RL   J. Biol. Chem. 272:14683-14689(1997).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11018011; DOI=10.1101/gad.836300;
RA   Schroeder S.C., Schwer B., Shuman S., Bentley D.;
RT   "Dynamic association of capping enzymes with transcribing RNA polymerase
RT   II.";
RL   Genes Dev. 14:2435-2440(2000).
RN   [9]
RP   3D-STRUCTURE MODELING OF 140-424, AND MUTAGENESIS OF GLU-170; ASP-194 AND
RP   ARG-206.
RX   PubMed=11472630; DOI=10.1186/1471-2105-2-2;
RA   Bujnicki J.M., Feder M., Radlinska M., Rychlewski L.;
RT   "mRNA:guanine-N7 cap methyltransferases: identification of novel members of
RT   the family, evolutionary analysis, homology modeling, and analysis of
RT   sequence-structure-function relationships.";
RL   BMC Bioinformatics 2:2-2(2001).
CC   -!- FUNCTION: Responsible for methylating the 5'-cap structure of mRNAs.
CC       {ECO:0000269|PubMed:7623811}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 5'-end (5'-triphosphoguanosine)-(ribonucleoside) in mRNA +
CC         S-adenosyl-L-methionine = a 5'-end (N(7)-methyl 5'-
CC         triphosphoguanosine)-ribonucleoside in mRNA + S-adenosyl-L-
CC         homocysteine; Xref=Rhea:RHEA:67008, Rhea:RHEA-COMP:17166, Rhea:RHEA-
CC         COMP:17167, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:156461,
CC         ChEBI:CHEBI:167617; EC=2.1.1.56;
CC         Evidence={ECO:0000250|UniProtKB:O43148, ECO:0000255|PROSITE-
CC         ProRule:PRU00895};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11018011}.
CC   -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC       superfamily. mRNA cap 0 methyltransferase family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00895}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L12000; AAA34383.1; -; Genomic_DNA.
DR   EMBL; Z36105; CAA85199.1; -; Genomic_DNA.
DR   EMBL; AY692770; AAT92789.1; -; Genomic_DNA.
DR   EMBL; BK006936; DAA07352.1; -; Genomic_DNA.
DR   PIR; S41782; S41782.
DR   RefSeq; NP_009795.3; NM_001178584.3.
DR   AlphaFoldDB; P32783; -.
DR   SMR; P32783; -.
DR   BioGRID; 32931; 346.
DR   DIP; DIP-2503N; -.
DR   IntAct; P32783; 10.
DR   MINT; P32783; -.
DR   STRING; 4932.YBR236C; -.
DR   iPTMnet; P32783; -.
DR   MaxQB; P32783; -.
DR   PaxDb; P32783; -.
DR   PRIDE; P32783; -.
DR   EnsemblFungi; YBR236C_mRNA; YBR236C; YBR236C.
DR   GeneID; 852538; -.
DR   KEGG; sce:YBR236C; -.
DR   SGD; S000000440; ABD1.
DR   VEuPathDB; FungiDB:YBR236C; -.
DR   eggNOG; KOG1975; Eukaryota.
DR   GeneTree; ENSGT00390000002368; -.
DR   HOGENOM; CLU_020346_2_0_1; -.
DR   InParanoid; P32783; -.
DR   OMA; WDATSIY; -.
DR   BioCyc; MetaCyc:G3O-29167-MON; -.
DR   BioCyc; YEAST:G3O-29167-MON; -.
DR   BRENDA; 2.1.1.56; 984.
DR   Reactome; R-SCE-72086; mRNA Capping.
DR   Reactome; R-SCE-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   PRO; PR:P32783; -.
DR   Proteomes; UP000002311; Chromosome II.
DR   RNAct; P32783; protein.
DR   GO; GO:0005829; C:cytosol; IDA:SGD.
DR   GO; GO:0005845; C:mRNA cap binding complex; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:SGD.
DR   GO; GO:0004482; F:mRNA (guanine-N7-)-methyltransferase activity; IDA:SGD.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; IDA:SGD.
DR   Gene3D; 3.40.50.150; -; 1.
DR   InterPro; IPR004971; mRNA_G-N7_MeTrfase_dom.
DR   InterPro; IPR016899; mRNA_G-N7_MeTrfase_euk.
DR   InterPro; IPR039753; RG7MT1.
DR   InterPro; IPR029063; SAM-dependent_MTases_sf.
DR   PANTHER; PTHR12189; PTHR12189; 1.
DR   Pfam; PF03291; Pox_MCEL; 1.
DR   PIRSF; PIRSF028762; ABD1; 1.
DR   SUPFAM; SSF53335; SSF53335; 1.
DR   PROSITE; PS51562; RNA_CAP0_MT; 1.
PE   1: Evidence at protein level;
KW   Methyltransferase; mRNA capping; mRNA processing; Nucleus;
KW   Reference proteome; RNA-binding; S-adenosyl-L-methionine; Transferase.
FT   CHAIN           1..436
FT                   /note="mRNA cap guanine-N7 methyltransferase"
FT                   /id="PRO_0000210134"
FT   DOMAIN          101..430
FT                   /note="mRNA cap 0 methyltransferase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        17..37
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         150..151
FT                   /ligand="mRNA"
FT                   /ligand_id="ChEBI:CHEBI:33699"
FT                   /ligand_part="mRNA cap"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   BINDING         154
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   BINDING         172
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   BINDING         194
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   BINDING         223
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:O43148"
FT   BINDING         249
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:O43148"
FT   BINDING         254
FT                   /ligand="S-adenosyl-L-methionine"
FT                   /ligand_id="ChEBI:CHEBI:59789"
FT                   /evidence="ECO:0000250|UniProtKB:O43148"
FT   SITE            175
FT                   /note="mRNA cap binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   SITE            181
FT                   /note="mRNA cap binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   SITE            206
FT                   /note="mRNA cap binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   SITE            253
FT                   /note="mRNA cap binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   SITE            347
FT                   /note="mRNA cap binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   SITE            416
FT                   /note="mRNA cap binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00895"
FT   MUTAGEN         168
FT                   /note="V->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         170
FT                   /note="E->A: Non-viable; reduced enzyme activity to 8% of
FT                   wild-type."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         170
FT                   /note="E->D: Still viable; increase in activity."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         170
FT                   /note="E->Q: Non-viable; reduced enzyme activity to 8% of
FT                   wild-type."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         172
FT                   /note="G->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         174
FT                   /note="G->A: Non viable; no growth."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         176
FT                   /note="G->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         178
FT                   /note="D->A: Microcolony formation."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         181
FT                   /note="K->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         182
FT                   /note="Y->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         194
FT                   /note="D->A: Lethal; no enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         194
FT                   /note="D->E: Still viable; activity near to wild-type."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         194
FT                   /note="D->N: Lethal; no enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         206
FT                   /note="R->A: Lethal."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         206
FT                   /note="R->K: Still viable; little change in enzyme
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:11472630,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         253
FT                   /note="H->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         254
FT                   /note="Y->A: Non viable; no growth."
FT                   /evidence="ECO:0000269|PubMed:8552073,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         254
FT                   /note="Y->F: Still viable; slow growth; near to wild-type
FT                   enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:8552073,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         254
FT                   /note="Y->S: Lethal; Enzyme activity 10% of wild-type."
FT                   /evidence="ECO:0000269|PubMed:8552073,
FT                   ECO:0000269|PubMed:9169431"
FT   MUTAGEN         276
FT                   /note="G->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         277
FT                   /note="G->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         282
FT                   /note="T->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         287
FT                   /note="E->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         347
FT                   /note="E->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         348
FT                   /note="Y->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         349
FT                   /note="V->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         350
FT                   /note="V->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         361
FT                   /note="E->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         362
FT                   /note="Y->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:8552073"
FT   MUTAGEN         363
FT                   /note="G->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         366
FT                   /note="L->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         367
FT                   /note="V->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   MUTAGEN         372
FT                   /note="F->A: Still viable; normal growth."
FT                   /evidence="ECO:0000269|PubMed:9169431"
FT   CONFLICT        126
FT                   /note="Y -> C (in Ref. 4; AAT92789)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   436 AA;  50341 MW;  EA5A68F0C4A57C4C CRC64;
     MSTKPEKPIW MSQEDYDRQY GSITGDESST VSKKDSKVTA NAPGDGNGSL PVLQSSSILT
     SKVSDLPIEA ESGFKIQKRR HERYDQEERL RKQRAQKLRE EQLKRHEIEM TANRSINVDQ
     IVREHYNERT IIANRAKRNL SPIIKLRNFN NAIKYMLIDK YTKPGDVVLE LGCGKGGDLR
     KYGAAGISQF IGIDISNASI QEAHKRYRSM RNLDYQVVLI TGDCFGESLG VAVEPFPDCR
     FPCDIVSTQF CLHYAFETEE KARRALLNVA KSLKIGGHFF GTIPDSEFIR YKLNKFPKEV
     EKPSWGNSIY KVTFENNSYQ KNDYEFTSPY GQMYTYWLED AIDNVPEYVV PFETLRSLAD
     EYGLELVSQM PFNKFFVQEI PKWIERFSPK MREGLQRSDG RYGVEGDEKE AASYFYTMFA
     FRKVKQYIEP ESVKPN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024